MRK Merck & Co., Inc.
Merck & Co., Inc. (MRK) is expected to report earnings on November 3, 2026, before the market open. The consensus earnings estimate is $2.27 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +5.7% since its last earnings release on August 4, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Merck & Co., Inc.
Merck & Co Inc is a health care company that delivers health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products.
Sector
Healthcare
Industry
Drug Manufacturers / Major
Held By 14 ETFs, by dollar flow
- XT iShares Exponential Technologies ETF
- OEF iShares S&P 100 ETF
- XLG Invesco S&P 500 Top 50 ETF
- IOO iShares Global 100 ETF
- DIA SPDR Dow Jones Industrial Average ETF
- DVY iShares Select Dividend ETF
- HDV iShares Core High Dividend ETF
- XLV Health Care Select Sector SPDR Fund
- IYH iShares U.S. Healthcare ETF
- IXJ iShares Global Healthcare ETF
- PPH VanEck Pharmaceutical ETF
- XPH SPDR S&P Pharmaceuticals ETF
- IHE iShares U.S. Pharmaceuticals ETF
- IDNA iShares Genomics Immunology and Healthcare ETF